Taken together, the findings not only indicate the connection of noncoding ZBTB20 transcripts with hepatic steatosis, but also suggest that the protective effect of BBR against NAFLD is associated with the expression of these lncRNAs. This evidence concerns the gene ZBTB20 and metabolic dysfunction-associated steatotic liver disease.